New Licence For Cerenia Offers Relief To Sick Cats And Puppies

The only anti-emetic to use maropitant citrate, Cerenia, has gained licenses for use in puppies from as young as eight weeks of age and now in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea. The licence for Cerenia’s use with cats in the injectable form provides a feline solution for the veterinary profession where the brand is already widely used and trusted in the prevention and treatment of vomiting in dogs.bi. Cerenia is an NK-1 receptor antagonist, effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis; it is the only NK-1 receptor antagonist licensed for dogs and cats. In addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomitingⁱⁱ and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans.ⁱⁱⁱ Furthermore, Cerenia tablets are the reliable treatment for motion sickness in dogs aged 16 weeks or older, delivering efficacy up to 93% without sedating the dog^iv. Kate Grocott, Product Manager for Cerenia, said of the new licence; “Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease^v.” The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets. For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034. References: ⁱ Ipsos Forward Research. Brand Health Assessement Emesis/Motion Sickness Feb – March 2012 ⁱⁱ Coates et al. On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983; 19(2): 203-208. ⁱⁱⁱ Jordan K, Kasper C and Schmoll HJ. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. European Journal of Cancer 2005; 41: 199–205 ^iv PAH Study 1963C-60-03-655 ^v European Emesis Council (EEC). Nausea Knowledge Statement 2010

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause